Ostrander GK

ORCID: 0000-0002-4804-6599 · 1 paper in corpus

2026

An Open Label, Cross-Over Phase 1 Study to Determine the Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of Niclosamide Under Fed and Fasted Conditions in Healthy Volunteers.

Journal of clinical medicine ·doi:10.3390/jcm15145330

Background/Objectives: Niclosamide is an U.S. Food and Drug Administration (FDA)-approved antihelminthic drug with a long-established safety profile and demonstrated in vitro antiviral activity against Zika virus. Its evaluation for systemi…